Patient P-01353
Synthetic patientNBL-101 · Day 114 · 25–34 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
44%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S07
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+18
- Inflammatory activity+15
- Nutritional resilience-12
- Treatment adherence-11
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion34.5/100
worsening · +10.0 vs previous 14 d
Toxicity
Blood13.5/100
improving · -1.1 vs previous 14 d
Sleep quality
Wearable33.2/100
worsening · -7.2 vs previous 14 d
Energy level
Daily log5.3/10
worsening · -0.9 vs previous 14 d
Stress level
Daily log4.8/10
worsening · +0.5 vs previous 14 d
Steps
Wearable7,207
stable · -110 vs previous 14 d
Adherence
Companion86.6 %
worsening · -8.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 71 from the failing basin, 20 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- HY-01 Hydration Protocolonly 38% improved among 8 similar
- Keep spicy lowGI +2.6 next day on high-intake days · n 23
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Spicy / capsaicin+2.6detractor · 67%
- Alcohol+2.1no signal · 48%
- Simple carbohydrates+1.9no signal · 31%
- Dietary fat load+0.5no signal · 15%
- Histamine load-0.5no signal · 15%
- Insoluble fibre-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↑45
- WearableResting HR 72 bpm
- WearableShort sleep window
- Inflammatory signalling ↑25
- DNAIL6 -174 variant raises baseline inflammatory tone
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.1 · butyrate capacity 51/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 48 ms
- Sleep
- 6.6 h
- Steps
- 8,366
- Resting HR
- 69 bpm
Daily log: GI score 35, nutritional resilience 57, adherence 87.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.